Mode
Text Size
Log in / Sign up
N/A Completed N=90 Basic Science

Neural Mechanisms of Successful Intervention in Children With Dyslexia

Dyslexia, Developmental
Source: ClinicalTrials.gov NCT04323488 ↗
Enrolled (actual)
90
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcomePrimary: White Matter Plasticity - Left Arcuate Tract — 0.837; 0.838; 0.842; 0.844 mm^2/s — p=0.925

Summary

Dyslexia, an impairment in accurate or fluent word recognition, is the most common learning disability affecting roughly ten percent of children. This proposal capitalizes on cutting edge neuroimaging methods, in combination with reading education programs, to generate a new understanding of how successful reading education shapes the development of the brain circuits that support skilled reading. A deeper understanding of the mechanisms of successful remediation of dyslexia, and individual differences in learning, will pave the way for personalized approaches to dyslexia treatment.

Outcome Measures

OutcomeResultp-value
PRIMARY
White Matter Plasticity - Left Arcuate Tract
0.837; 0.838; 0.842; 0.844; 0.839; 0.830 0.925
PRIMARY
White Matter Plasticity - Inferior Longitudinal Tract
0.963; 0.957; 0.963; 0.956; 0.957; 0.952 0.524
PRIMARY
Visual Word Form Area (VWFA) Size
142.00; 302.74; 146.69; 282.40; 375.53; 337.20 0.60
PRIMARY
Woodcock-Johnson Basic Reading Skills (WJ BRS) Assessment Battery
80.75; 96.85; 88.33; 96.02; 89.95; 95.10 < 0.001 sig

Eligibility Criteria

Inclusion Criteria

  • Reading difficulties defined as low scores on standardized measures of reading skills

Exclusion Criteria

  • no major contraindication for MRI (braces, metal implants, pacemakers, vascular stents, or metallic ear tubes).
  • Because the study involves measurements of reading and language ability, new recruits will be native English speakers.
  • Subjects have no history of neurological disorder, significant psychiatric problems
  • exclude claustrophobic subjects since an MRI might be uncomfortable for them.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04323488). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search